Navigation Links
Sinovac Requests Extension for Annual Shareholders Meeting
Date:12/13/2007

BEIJING, Dec. 13 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that it has notified the Listing Qualifications Department at the American Stock Exchange that the Company will defer its 2007 annual stockholders meeting to no later than April 30, 2008.

The Company originally scheduled its 2007 annual stockholders meeting in August 2007. The meeting was postponed because the Company could not form the necessary quorum, which is 50% of the outstanding shares based on the Company's by-laws. The Company does not believe that it will be able to form the necessary quorum to hold the 2007 annual meeting by year-end, and it is continuing to evaluate different options as an Antigua corporation and a foreign private issuer.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccines include Healive(TM) (hepatitis A), Bilive(TM) (combined hepatitis A and B) and Anflu(TM) (influenza). Sinovac is currently developing human vaccines against the H5N1 strain of pandemic influenza, and Japanese encephalitis. Additional information about Sinovac is available on its website, http://www.sinovac.com. To be added to our distribution list, please email: info@sinovac.com.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sinovac Announces Postponement of Annual General Meeting
2. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
3. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
4. Sysmex America Awarded MedAssets Supply Chain Systems Hematology Contract Extension
5. AMDL Announces Filing of Extension on Third Quarter 2007 Form 10-QSB
6. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
7. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
8. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
9. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
10. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
11. ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... CHESTERBROOK, Pa. , Sept. 29, 2014 /PRNewswire/ ... of the largest global pharmaceutical sourcing and distribution ... analysis on coffee consumption. This research was analyzed ... coffee consumption was associated with an increase in ... The study looked at population-level coffee consumption across ...
(Date:9/27/2014)... the peer-reviewed Journal of Animal Science concludes ... has no impact on the health or productivity of ... and field data sets, the article documents evidence that ... crops are comparable with those of animals fed non-GE ... feed crops have become an increasing component of livestock ...
(Date:9/27/2014)... Researchers from The University of Texas at Dallas have ... wearable computers with self-contained power sources or, more immediately, ... of heavy use. , This technology, published online in ... power of a single electron to control energy consumption ... modern electronic systems. , Researchers from the Erik Jonsson ...
(Date:9/26/2014)... , Sept. 26, 2014  MicroBiome Therapeutics ... results from a proof of concept study testing ... the tolerability of metformin, the first-line therapy for ... of metformin and active ingredients contained in the ... an effective, safe and inexpensive medication, is recommended ...
Breaking Biology Technology:Coffee Consumption May Increase Survival and Reduce Healthcare Costs 2Coffee Consumption May Increase Survival and Reduce Healthcare Costs 3New UT Dallas technology may lead to prolonged power in mobile devices 2New UT Dallas technology may lead to prolonged power in mobile devices 3Positive Proof Of Concept Study Shows MicroBiome Therapeutics' NM505 May Improve Tolerability Of Metformin In Type 2 Diabetes 2Positive Proof Of Concept Study Shows MicroBiome Therapeutics' NM505 May Improve Tolerability Of Metformin In Type 2 Diabetes 3
... Calif., May 6 Finesse Solutions, LLC,Santa ... control solutions for,life sciences process applications, announced ... of Software. Basil brings over 19 years ... a focus on,implementing high efficiency engineering, resource ...
... Award at Leading Venture Contest Makes Carnegie Mellon ,Winningest, ... ... time, a team of,students from the Tepper School of Business at Carnegie ... competition Moot,Corp(R). This year,s winning venture business -- NeuroBank -- has developed,a ...
... Md., May 6 PharmAthene, Inc.,(Amex: PIP ) ... threats, announced today that its financial results,for the first ... 13, 2008., PharmAthene management will be hosting a ... The call is scheduled to begin at,4:30 p.m. Eastern ...
Cached Biology Technology:Basil Zimmo Joins Finesse Solutions as Vice-President of Software 2Tepper School Team Takes Top Honors at Global Moot Corp(R) Competition 2PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008 2
(Date:9/29/2014)... Monday, September 29: Between 1970 and 2010 populations ... the globe dropped 52 percent, says the 2014 ... Fund (WWF). This biodiversity loss occurs disproportionately in ... of high-income countries. , In addition to the ... point to other warning signs about the overall ...
(Date:9/29/2014)... Texas at Arlington research team says recently identified radiation ... lab could open doors for homeland security and medical ... the Oct. 1 issue of Optics Letters , ... describe a new method to fabricate transparent nanoscintillators by ... a transparent ceramic is formed. A scintillator refers ...
(Date:9/29/2014)... received a five-year, $6 million grant for clinical ... and development of safe and effective treatments for ... the National Institutes of Health, National Institute on ... Medication Development for Cocaine Use Disorder to oversee ... decisions on moving forward with more expensive large-scale ...
Breaking Biology News(10 mins):Half of global wildlife lost, says new WWF report 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 3New VCU center to target cocaine addiction 2
... of a tiny shrimp-like species, known scientifically as ... non-native quagga mussels in the Great Lakes, say NOAA ... Diporeia and many aquatic species have steadily ... NOAA,s Great Lakes Environmental Laboratory published,this week in ...
... University have developed a new tool that makes it possible ... generation of blood vessels. The researchers, findings, published in ... enable scientists to determine what signals in the body attract ... tumor research. The new invention is a tiny cell ...
... a startling result, a new study published by the ... than 80 percent of the world,s major armed conflicts ... biologically diverse and threatened places on Earth. Titled ... conservation scientists compared major conflict zones with the Earth,s ...
Cached Biology News:Tiny tool to control growing blood vessels opens new potential in tumor research 2Study finds most wars occur in Earth's richest biological regions 2Study finds most wars occur in Earth's richest biological regions 3
Preparation TW--Compatibility: Push-on end cap seals suitable up to 70 C only -Hybridization Tube for Model HB-1D -Comp Dim: 200 80 mm -Material: borosilicate glass -Mfr Desig: Techne FHB-12...
Preparation TW--Compatibility: no end cap seals -Hybridization Tube for Hybrigene -Comp Dim: 240 80 mm -Material: borosilicate glass -Mfr Desig: Techne FHB-15...
...
... in hybridization incubators with rotators. Graduated, ... size PP plug-seal screw-cap with O-ring ... three lengths to accept different size ... O-rings available separately. • Comp Dim: ...
Biology Products: